Clinical Trials

40 enrolled

Leukemia, Myeloid, Acute

NCT05951855 2023-07-19

Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients

42 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT05949762 2023-07-18

Safety and Efficacy of Venetoclax in Combination With Azacitidine and HA Regimen in the Treatment of AML in the Elderly

45 enrolled

Phase EARLY_PHASE1 Unknown

Leukemia, Myeloid, Acute

NCT04923919 2023-07-13

Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Myeloid Leukemia

100 enrolled

Leukemia, Myeloid, Acute

NCT05919199 2023-06-26

FDG-PETAML

60 enrolled

Leukemia, Myeloid, Acute

NCT05264883 2023-05-30

Venetoclax+HMA+Aclarubicin Versus Venetoclax+HMA in Treatment-Naive Elderly Patients With AML

170 enrolled

Leukemia, Myeloid, Acute

NCT05140811 2023-05-24

A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

MyeloidOther hematologic neoplasm

126 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04217278 2023-05-10

COSI

Phase 2/3 Unknown

333 enrolled

Leukemia, Myeloid, Acute

NCT05805072 2023-05-06

Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients

20 enrolled

Leukemia, Myeloid, Acute

NCT05823714 2023-04-21

Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT

MyeloidOther hematologic neoplasm

70 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05697510 2023-04-06

SILTUXILAM

Leukemia, Myeloid, Acute

NCT05791890 2023-03-30

GilteRInf

78 enrolled

Infections, Leukemia, Myeloid, Acute

NCT02931942 2023-03-16

Changing Over Time of Ascorbic Acid After Chemotherapy

Other hematologic neoplasmPlasma cellThoracic

150 enrolled

Leukemia, Lung Neoplasms, Leukemia, Myeloid, Acute, Neoplasms, Plasma Cell

NCT03846362 2023-03-16

A Prospective Multicenter Clinical Trial of MRD-based Treatment Strategy in Children and Young Adults With AML

500 enrolled

Leukemia, Leukemia, Myeloid, Acute

NCT05312112 2023-03-02

Real World Outcomes Using Novel Agents for AML in the UK

1,000 enrolled

Phase EARLY_PHASE1 Unknown

Leukemia, Myeloid, Acute

NCT05744440 2023-02-27

Safety and Efficacy of Allogenic NK Cells in Combination With Chemotherapy in the Treatment of r/r AML After Allo-HSCT

Leukemia, Myeloid, Acute

NCT03533816 2023-02-08

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

LymphoidMyeloidOther hematologic neoplasm

38 enrolled

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05665114 2023-01-03

Natural Killer(NK) Cell Therapy in r/r AML

18 enrolled

Leukemia, Myeloid, Acute

NCT05654194 2022-12-16

Azacitidine Combined With Venetoclax and ATRA in Newly Diagnosed AML

30 enrolled

Phase EARLY_PHASE1 Unknown

Leukemia, Myeloid, Acute

NCT05519384 2022-11-28

Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia

Leukemia, Leukemia, Myeloid, Acute

NCT03855371 2022-11-04

PANDA-T0

5 enrolled

Leukemia, Myeloid, Acute

NCT05596968 2022-10-27

The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD Positive AML After Allo-HSCT

37 enrolled

Leukemia, Myeloid, Acute

NCT05596981 2022-10-27

The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or Without Sorafenib Maintenance After Allo-HSCT

60 enrolled

Leukemia, Myeloid, Acute

NCT05587088 2022-10-19

PA001

GastrointestinalLymphoidOther hematologic neoplasm

82 enrolled

Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05577611 2022-10-13

An Open, Single Center, Randomized Controlled Clinical Study of UCB (Cord Blood) in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

57 enrolled

Leukemia, Myeloid, Acute

NCT03825367 2022-10-12

Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML

13 enrolled

Leukemia, Recurrence, Leukemia, Myeloid, Acute

NCT04226768 2022-10-04

Enhanced Palliative Care in MDS and AML

MyeloidOther hematologic neoplasm

90 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04689815 2022-10-04

Oral Arsenic Trioxide for NPM1-mutated AML

50 enrolled

Leukemia, Myeloid, Acute

NCT04248595 2022-09-08

Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML

100 enrolled

Leukemia, Myeloid, Acute

NCT04687761 2022-09-08

Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old

84 enrolled

Leukemia, Myeloid, Acute

NCT05512104 2022-08-23

Clinical Characters and Outcome of Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56 Expression

51 enrolled

Leukemia, Myeloid, Acute

NCT05488132 2022-08-04

Administration of Anti-siglec-6 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)

20 enrolled

Leukemia, Myeloid, Acute

NCT03173612 2022-08-03

The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia

132 enrolled

Leukemia, Myeloid, Acute

NCT05457361 2022-07-14

VAH Versus VA for Salvage Therapy of R/R-AML

162 enrolled

Leukemia, Myeloid, Acute

NCT05382390 2022-05-19

Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial

130 enrolled

Leukemia, Myeloid, Acute

NCT05383014 2022-05-19

FLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid Leukemia.

82 enrolled

Leukemia, Myeloid, Acute

NCT04886206 2022-05-11

ILDA

Leukemia, Myeloid, Acute

NCT05362942 2022-05-05

Combination of Venetoclax, Hypomethylation Agent and Low-dose Cytarabine as a Salvage Therapy for Acute Myeloid Leukemia

52 enrolled

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT05154474 2022-05-03

SPACE2

BreastClassical hematologyGastrointestinalGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

150 enrolled

Anemia, Refractory, with Excess of Blasts, Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Sarcopenia

NCT05330364 2022-04-29

Study of Chidamide Combined With Cladribine in Refractory/Relapsed Acute Myeloid Leukemia

31 enrolled

Leukemia, Myeloid, Acute

NCT05053425 2022-04-26

Bcl-2 Inhibitors Combined With Azacytidine and Chemotherapy in Elderly Patients With Previously Untreated AML

30 enrolled